We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for October 31st
Read MoreHide Full Article
Here are four stocks with buy ranks and strong momentum characteristics for investors to consider today, October 31st:
Acacia Communications, Inc. : This provider of high-speed coherent interconnect products carries a Zacks Rank #1 (Strong Buy), as the Zacks Consensus Estimate for its current year earnings has advanced 6.1% over the last 30 days.
Allison Transmission Holdings, Inc. (ALSN - Free Report) : This manufacturer of commercial and defense fully-automatic transmissions for medium- and heavy-duty commercial vehicles has seen the Zacks Consensus Estimate for its current year earnings soaring 5.1% over the last 30 days. As a result, it holds a Zacks Rank #1.
Arch Capital Group Ltd. (ACGL - Free Report) : This provider of property, casualty, and mortgage insurance and reinsurance products has seen the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 30 days. As a result, it carries a Zacks Rank #2 (Buy).
Ariad Pharmaceuticals Inc. : this oncology company holds a Zacks Rank #2, as the Zacks Consensus Estimate for its current year earnings has surged 21.6% over the last 30 days.
You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research. See the stocks free >>.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Top Ranked Momentum Stocks to Buy for October 31st
Here are four stocks with buy ranks and strong momentum characteristics for investors to consider today, October 31st:
Acacia Communications, Inc. : This provider of high-speed coherent interconnect products carries a Zacks Rank #1 (Strong Buy), as the Zacks Consensus Estimate for its current year earnings has advanced 6.1% over the last 30 days.
ACACIA COMMUNIC Price and Consensus
ACACIA COMMUNIC Price and Consensus | ACACIA COMMUNIC Quote
Acacia Communications’ year-to-date return is a whopping 130.2%. The company possess a Momentum Score of A.
ACACIA COMMUNIC Price
ACACIA COMMUNIC Price | ACACIA COMMUNIC Quote
Allison Transmission Holdings, Inc. (ALSN - Free Report) : This manufacturer of commercial and defense fully-automatic transmissions for medium- and heavy-duty commercial vehicles has seen the Zacks Consensus Estimate for its current year earnings soaring 5.1% over the last 30 days. As a result, it holds a Zacks Rank #1.
ALLISON TRANSMN Price and Consensus
ALLISON TRANSMN Price and Consensus | ALLISON TRANSMN Quote
Allison Transmission’s year-to-date return is 13.3%. The company possess a Momentum Score of B.
ALLISON TRANSMN Price
ALLISON TRANSMN Price | ALLISON TRANSMN Quote
Arch Capital Group Ltd. (ACGL - Free Report) : This provider of property, casualty, and mortgage insurance and reinsurance products has seen the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 30 days. As a result, it carries a Zacks Rank #2 (Buy).
ARCH CAP GP LTD Price and Consensus
ARCH CAP GP LTD Price and Consensus | ARCH CAP GP LTD Quote
Arch Capital’s year-to-date return is 11.1%, compared with the S&P 500’s return of 4.2%. The company possess a Momentum Score of A.
ARCH CAP GP LTD Price
ARCH CAP GP LTD Price | ARCH CAP GP LTD Quote
Ariad Pharmaceuticals Inc. : this oncology company holds a Zacks Rank #2, as the Zacks Consensus Estimate for its current year earnings has surged 21.6% over the last 30 days.
ARIAD PHARMA Price and Consensus
ARIAD PHARMA Price and Consensus | ARIAD PHARMA Quote
Ariad Pharmaceuticals’ year-to-date return is 40.5%. The company carries a Momentum Score of A.
ARIAD PHARMA Price
ARIAD PHARMA Price | ARIAD PHARMA Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here
Want to see all of today's Zacks Strong Buys?
You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research. See the stocks free >>.